US09075V1026
US09075V1026
BioNTech SE
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.869.900.000 | 2.751.100.000 | 4.3% |
| Cost of Revenue | 641.800.000 | 541.300.000 | 18.6% |
| Gross Profit | 2.228.100.000 | 2.209.800.000 | 0.8% |
| 2.868.800.000 | 2.919.200.000 | 1.7% | |
| Operating Income | -640.700.000 | -709.400.000 | 9.7% |
| Pretax Income | -1.050.800.000 | -677.700.000 | 55.1% |
| Net Income Common Stockholders | -1.136.100.000 | -665.300.000 | 70.8% |
| -- | -- | -- | |
| -- | -- | -- |